End of Enrollment for Pediatric Phase III Trial
GCT has successfully concluded enrollment for the Phase III pediatric study of rare neurological disease in Russia.
Reaching the exact recruitment number, as predicted and in under 1.5 months marks an important milestone for our company
and the Sponsor – US Pharma and GCT long term partner.
January 22, 2020
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
Taj Lands End
2020, January 24—25
Austin, Texas, USA
2020, January 31 — February 1
Washington, District of Columbia, USA
2020, January 18—19
Hotel Cascais Miragem
2020, March 9—10